全文获取类型
收费全文 | 1334285篇 |
免费 | 95958篇 |
国内免费 | 2904篇 |
专业分类
耳鼻咽喉 | 19713篇 |
儿科学 | 40228篇 |
妇产科学 | 38660篇 |
基础医学 | 187213篇 |
口腔科学 | 39810篇 |
临床医学 | 112628篇 |
内科学 | 262378篇 |
皮肤病学 | 30205篇 |
神经病学 | 106408篇 |
特种医学 | 53667篇 |
外国民族医学 | 435篇 |
外科学 | 208228篇 |
综合类 | 31044篇 |
现状与发展 | 6篇 |
一般理论 | 436篇 |
预防医学 | 92060篇 |
眼科学 | 31360篇 |
药学 | 100062篇 |
4篇 | |
中国医学 | 2987篇 |
肿瘤学 | 75615篇 |
出版年
2018年 | 11742篇 |
2015年 | 11875篇 |
2014年 | 16690篇 |
2013年 | 25249篇 |
2012年 | 33010篇 |
2011年 | 34878篇 |
2010年 | 20735篇 |
2009年 | 20227篇 |
2008年 | 33575篇 |
2007年 | 36686篇 |
2006年 | 37259篇 |
2005年 | 36014篇 |
2004年 | 35084篇 |
2003年 | 34066篇 |
2002年 | 33586篇 |
2001年 | 63614篇 |
2000年 | 65322篇 |
1999年 | 55388篇 |
1998年 | 14650篇 |
1997年 | 13458篇 |
1996年 | 12939篇 |
1995年 | 12221篇 |
1994年 | 11467篇 |
1992年 | 42761篇 |
1991年 | 41281篇 |
1990年 | 40553篇 |
1989年 | 39550篇 |
1988年 | 36963篇 |
1987年 | 36408篇 |
1986年 | 34900篇 |
1985年 | 33101篇 |
1984年 | 24822篇 |
1983年 | 21052篇 |
1982年 | 12665篇 |
1981年 | 11569篇 |
1980年 | 10773篇 |
1979年 | 23923篇 |
1978年 | 17068篇 |
1977年 | 14834篇 |
1976年 | 13386篇 |
1975年 | 15267篇 |
1974年 | 18080篇 |
1973年 | 17560篇 |
1972年 | 16810篇 |
1971年 | 15717篇 |
1970年 | 14914篇 |
1969年 | 14346篇 |
1968年 | 13460篇 |
1967年 | 12015篇 |
1966年 | 11258篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
53.
E. M. Peterman C. Sullivan M. F. Goody I. Rodriguez-Nunez J. A. Yoder C. H. Kim 《Infection and immunity》2015,83(1):430-440
Mitochondria are known primarily as the location of the electron transport chain and energy production in cells. More recently, mitochondria have been shown to be signaling centers for apoptosis and inflammation. Reactive oxygen species (ROS) generated as by-products of the electron transport chain within mitochondria significantly impact cellular signaling pathways. Because of the toxic nature of ROS, mitochondria possess an antioxidant enzyme, superoxide dismutase 2 (SOD2), to neutralize ROS. If mitochondrial antioxidant enzymes are overwhelmed during severe infections, mitochondrial dysfunction can occur and lead to multiorgan failure or death. Pseudomonas aeruginosa is an opportunistic pathogen that can infect immunocompromised patients. Infochemicals and exotoxins associated with P. aeruginosa are capable of causing mitochondrial dysfunction. In this work, we describe the roles of SOD2 and mitochondrial ROS regulation in the zebrafish innate immune response to P. aeruginosa infection. sod2 is upregulated in mammalian macrophages and neutrophils in response to lipopolysaccharide in vitro, and sod2 knockdown in zebrafish results in an increased bacterial burden. Further investigation revealed that phagocyte numbers are compromised in Sod2-deficient zebrafish. Addition of the mitochondrion-targeted ROS-scavenging chemical MitoTEMPO rescues neutrophil numbers and reduces the bacterial burden in Sod2-deficient zebrafish. Our work highlights the importance of mitochondrial ROS regulation by SOD2 in the context of innate immunity and supports the use of mitochondrion-targeted ROS scavengers as potential adjuvant therapies during severe infections. 相似文献
54.
55.
56.
57.
58.
59.
Paul J. Devlin Brian W. McCrindle James K. Kirklin Eugene H. Blackstone William M. DeCampli Christopher A. Caldarone Ali Dodge-Khatami Pirooz Eghtesady James M. Meza Peter J. Gruber Kristine J. Guleserian Bahaaladin Alsoufi Linda M. Lambert James E. OBrien Erle H. Austin Jeffrey P. Jacobs Tara Karamlou 《The Journal of thoracic and cardiovascular surgery》2019,157(2):684-695.e8
Objective
Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.Methods
From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.Results
Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).Conclusions
Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes. 相似文献60.